Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan

Journal of Oral Pathology and Medicine

Volumn 28, Issue 5, 1999, Pages 221-225

  Kuo, Mark Yen Ping ^a   Huang, Jehn Shyun ^a   Hsu, Hey Chi ^a   Chiang, Chun Pin ^a   Kok, Sang Heng ^a   Kuo, Ying Shiung ^a   Hong, Chi Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Areca quid chewing; Oral cancer; P53 mutation

Indexed keywords

ARGININE; GENE MUTATION; GLYCINE; LEUCINE; P53 MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROLINE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

EID: 0033134681     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb02028.x     Document Type: Article

References (43)

1. DONEHOWER LA, BRADLEY A. The tumor suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
2. CHANG F, SYRJANEN S, TERVAHAUTA, SYRJANEN K. Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993; 68: 653-61.
3. GREENBLATT MS, BENNETT WP, HOLLSTEIN, HARRIS CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
4. KASTAN MB, ONYEKWERE O, SIDRANSKY D, VOGELSTEIN B, CRAIG RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
5. KASTAN MB, ZHAN Q, EL-DEIRY WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-97.
6. SOUSSI T, CARON DE FROMENTEL C, MAY P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 1990; 5: 945-52.
7. BENNET WP, HOLLSTEIN MC, HE A, et al. Archival analysis of p53 genetic and protein alteration in Chinese oesophageal cancer. Oncogene 1991; 6: 1779-84.
8. GUSTERSON BA, ANBAZHAGAN R, WARREN W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785-9
9. BURNS JE, BAIRD MC, CLARK LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993; 67: 1274-84.
10. AHOMADEGBE JC, BARROIS M, FOGEL S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995; 10: 1217-27.
11. RANASINGHE A, MACGEOCH C, DYER S, SPURR N, JOHNSON NW. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5-9. Anticancer Res 1993; 13: 2065-8.
12. MELHEM MF, LAW JC, EL-ASHMAWY L, et al. Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol 1995; 146: 1170-7.
13. LAZARUS P, STERN J. ZWIEBEL N, FAIR A, RICHIE JR JP, SCHANTZ S. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis 1996; 17: 733-9.
14. IARC. Betel-quid and areca-nut chewing. Lyon: International Agency for Research on Cancer Monographs, 1986; 37: 141-202.
15. KO YC, CHIANG TA, CHANG SJ, HSIEH SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992; 21: 261-4.
16. KWAN HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel quid chewing: a preliminary report. J Formos Med Assoc 1976; 75: 497-505.
17. CHIANG C-P, HUANG J-S, WANG J-T, et al. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 72-6.
18. HUANG J-S, CHIANG C-P, K.OK S-H, KUO Y-S, KUO MY-P. Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1997; 26: 322-6.
19. HSU H-C, HUANG A-M, LAI P-L, CHIEN W-M, PENG S-Y, LIN S-W. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hepatology 1994; 19: 122-8.
20. DON RH, COX PT, WAINWRIGHT BJ, BAKER K, MATTICK JS. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acid Res 1991; 19: 4008.
21. SAKAI E, TSUCHIDA N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor suppressor genes. Oncogene 1992; 7: 927-33.
22. MAO EJ, SCHWARTZ SM, DALING JR, ODA D, TICKMAN L, BECKMANN AM. Human papilloma viruses and p53 mutations in normal, premalignant and malignant oral epithelia. Int J Cancer 1996; 69: 152-8.
23. THOMAS S, BRENNAN J, MARTEL G, et al. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res 1994; 54: 3588-93.
24. RANASINGHE AW, WARNAKULASURIYA KAAS, JOHNSON NW. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Eur J Cancer B Oral Oncol 1993; 29: 147-50.
25. CHANG YS, LIN YJ, TSAI CN, et al. Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Lett 1992; 67: 167-74.
26. WONG Y-K, LIU T-Y, CHANG K-W, et al. p53 alterations in betel quid-and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 1998; 27: 243-8.
27. TRIVEDY C, WARNAKULASURIYA KAAS, TAVASSOLI M, et al. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med 1998; 27: 72-7.
28. TRIVEDY C, BALDWIN D, WARNAKULASURIYA S, JOHNSON N, PETERS T. Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 1997; 349: 1447.
29. NAIR UJ, NAIR J, FRIESEN MD, BARTSCH H, OHSHIMA H. Ortho- and meta-tyrosine formation from phenylalanine in human saliva as a marker of hydroxyl radical generation during betel quid chewing. Carcinogenesis 1995; 16: 1195-8.
30. FIELD JK. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer 1992; 28B: 67-76.
31. KUO MYP, JENG JH, CHIANG CP, HAHN LJ. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 1994; 23: 70-4.
32. KUO MYP, CHANG HH, HAHN LJ, WANG JT, CHIANG CP. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 1995; 24: 255-60.
33. LEVINE AJ, WU MC, CHANG A, et al. The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann NY Acad Sci 1995; 768: 111-28.
34. BOYLE JO, HAKIM J, KOCH W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477-80.
35. HALL PA, MCKEE PH, MENAGE HD, DOVER R, LANE DP. High levels of p53 protein in UV irradiated normal human skin. Oncogene 1993; 8: 203-7.
36. KASTAN MB, ONYEKWERE O, SIDRANSKY D, VOLGELSTEIN B, CRAIG RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
37. SNIJDERS PJF, VAN DEN BRULE AJC, MEIJER CJLM, WALBOOMERS JMM. Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Top Microbiol Immunol 1994; 186: 177-98.
38. SCHEFFNER M, WERNESS BA, HUIBREGTSE JM, LEVINE AJ, HOWLEY PM. The E6 oncoprotein encoded by human papilloma virus type 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
39. SNIJDERS PJF, STEENBERGER RDM, TOP B, SCOTT SD, MEIJER CJLM, WALBOOMERS JMM. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 1994; 75: 2769-75.
40. DEMERS GW, HALBERT CL, GALLOWAY DA. Elevated wild type p53 protein in human epithelial cell lines immortalized by the human papillomavirus 16 E7 gene. Virology 1994; 198: 169-74.
41. CHANG KW, CHANG CS, LAI KS, CHOU MJ, CHOO KB. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989; 28: 57-61.
42. MATSUMURA T, YOSHIHAMA Y, KIMURA T, SHINTANI S, ALCALDE RE. p53 and MDM2 expression in oral squamous cell carcinoma. Oncology 1996; 53: 308-12.
43. UICC. TNM classification of malignant tumours. 4th edn. 2nd revision. HERMANEK P, SOBIN LH, eds. Berlin: Springer, 1992.